Chemomab Therapeutics Ltd Adr has split its stock once since its initial public offering (IPO). The stock split of Chemomab Therapeutics Ltd Adr occurred on August 26, 2025 on a 1-for-4 basis, meaning that for 4 shares of CMMB owned pre-split, shareholders then owned 1 share.
This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on Chemomab Therapeutics Ltd Adr's total market capitalization.
The answer will depend on the decisions of the company's managers and market volatility. Chemomab Therapeutics Ltd Adr has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when CMMB stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Chemomab Therapeutics Ltd Adr's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
